Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Biochimica Et Biophysica Acta. General Subjects|September 25, 2018
Identification of amino acid residues critical for the B cell growth-promoting activity of HIV-1 matrix protein p17 variantsWangxiao He, Pietro Mazzuca, Weirong Yuan, et al.
Scientific Reports|March 23, 2016
Integrating computational and chemical biology tools in the discovery of antiangiogenic small molecule ligands of FGF2 derived from endogenous inhibitorsChiara Foglieni, Katiuscia Pagano, Marco Lessi, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2012
HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2Francesca Caccuri, Cinzia Giagulli, Antonella Bugatti, et al.
Scientific Reports|December 2, 2016
Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17Francesca Caccuri, Maria Luisa Iaria, Federica Campilongo, et al.
Molecules (Basel, Switzerland)|January 11, 2018
Speeding Up the Identification of Cystic Fibrosis Transmembrane Conductance Regulator-Targeted Drugs: An Approach Based on Bioinformatics Strategies and Surface Plasmon ResonanceMarco Rusnati, Davide Sala, Alessandro Orro, et al.
Microorganisms|August 7, 2021
SARS-CoV-2 Infection Remodels the Phenotype and Promotes Angiogenesis of Primary Human Lung Endothelial CellsFrancesca Caccuri, Antonella Bugatti, Alberto Zani, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2020
Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietinFrancesca Caccuri, Pasqualina D'Ursi, Matteo Uggeri, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 28, 2022
HIV-1 mutants expressing B cell clonogenic matrix protein p17 variants are increasing their prevalence worldwideFrancesca Caccuri, Serena Messali, Alberto Zani, et al.
Angiogenesis|September 1, 2018
The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2)Marco Rusnati, Patrizia Borsotti, Elisabetta Moroni, et al.
Oncotarget|September 30, 2015
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug deliveryChiara Romani, Emiliano Cocco, Eliana Bignotti, et al.
Pageof 7